Abstract
Colorectal cancer (CRC) is a major cause of morbidity and mortality in France. Only scanty data on cost-effectiveness of CRC screening in Europe are available, generating uncertainty over its efficiency. Although immunochemical fecal tests (FIT) and guaiac-based fecal occult blood tests (g-FOBT) have been shown to be cost-effective in France, cost-effectiveness of endoscopic screening has not yet been addressed.
| Original language | English |
|---|---|
| Pages (from-to) | 780-793 |
| Number of pages | 14 |
| Journal | Endoscopy |
| Volume | 43 |
| DOIs | |
| Publication status | Published - 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Capsule Endoscopy
- Colonoscopy
- Colorectal Neoplasms
- Computer Simulation
- Cost-Benefit Analysis
- France
- Humans
- Markov Chains
- Mass Screening
- Occult Blood
- Sigmoidoscopy
Fingerprint
Dive into the research topics of 'Cost effectiveness and projected national impact of colorectal cancer screening in France'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver